<DOC>
	<DOCNO>NCT02062723</DOCNO>
	<brief_summary>The efficacy tolerability Eptadone® context maintenance program evaluate observational prospective , multicenter study , heroin addict patient .</brief_summary>
	<brief_title>Observational Study Assess Efficacy Tolerability Eptadone® , Heroin Addicted Patients MMT</brief_title>
	<detailed_description>515 patient select among patient addict heroin accord ICD-10 , maintenance treatment Eptadone , observe involve site . The investigator use treatment scheme Eptadone conform register use . The enrollment competitive . Patients meet incl/excl sign informed consent observe 1 year . Follow visit perform accord routine procedure , patient related centre 3/6/12 month post V1 . During visit patient assess validate used clinical practice questionaries . Safety tolerability assess collection adverse reaction laboratory test .</detailed_description>
	<mesh_term>Behavior , Addictive</mesh_term>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<mesh_term>Heroin</mesh_term>
	<criteria>Both sex Over 18 year age Patients diagnosis heroin addiction , accord ICD10 ( International Classification Diseases10 ) Patients receive `` maintenance treatment '' Eptadone® since least one month Accession observational study inform consent Inability follow observation understand study procedure follow Diagnosis : Decompensated psychotic disorder , Epileptic attack , relate drug abuse , Severeacute severechronic somatic disease ( like AIDS , Tubercolosis , acute hepatitis , Sepsis ecc ) , whereas chronical HCV exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>methadone</keyword>
	<keyword>heroin addiction</keyword>
	<keyword>methadone maintenance treatment</keyword>
	<keyword>adequate dosage methadone</keyword>
</DOC>